Bipolar Disorder clinical trials
The registry lists 1,683 studies for Bipolar Disorder across more than 10 countries. 266 are recruiting or about to start. 1,083 of them are mainly about Bipolar Disorder (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10.
ClinicalTrials.gov finds 2,070 studies for Bipolar Disorder. How that becomes 1,683 here
This page counts the studies the registry files under Bipolar Disorder, and those it files under no condition that list Bipolar Disorderthemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 8, 2026. How condition pages count
- 2,070Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
- −23List Bipolar Disorder as a condition, but the registry did not file them under itMost often written as “Bipolar Disorder With Psychotic Features” (8), “Severe Bipolar Disorder With Psychotic Features” (2), and “Bipolar Disorder With Psychosis” (2). The registry filed them under other conditions only, most often Schizophrenia (15) and Psychotic Disorders (14).
- −364Match it another way49 name it in the title, 2 in a keyword, and 313 by a synonym or other text the search reads.
- 1,683The count on this page14 of them list Bipolar Disorder in their own words; the registry filed them under no condition.
Get an email when these change. Save the Bipolar Disorder studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
Massachusetts General Hospital (63) · AstraZeneca (47) · National Institute of Mental Health (NIMH) (41) · Mclean Hospital (33) · Stanford University (23) · University of Pittsburgh (22) · University of Texas Southwestern Medical Center (22) · Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (21)
What is being tested here
Drugs under test in Bipolar Disorder studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Lumateperone | 3 | 8 | 9 |
| Lurasidone | 2 | 11 | 17 |
| Cariprazine | 2 | 3 | 9 |
| Venlafaxine | 2 | 2 | 8 |
| Escitalopram | 2 | 2 | 7 |
| Bupropion | 2 | 2 | 7 |
| Dexmedetomidine | 2 | 2 | 6 |
| Psilocybin | 2 | 0 | 5 |
| Melatonin | 2 | 0 | 5 |
| Cannabidiol | 2 | 2 | 4 |
Drug classes tested here Antipsychotics 5 open · GLP-1 receptor agonists 3 open · SSRIs 2 open · Serotonin receptor agonists 2 open · NSAIDs 1 open
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
The 10 nearest, phase 3 first
- Jan 2027Evaluation of the Efficacy, Safety, and Tolerability of Lacosamide in Major Depressive Episodes of Bipolar Disorder Types I and II. · Phase 3 · University of Sao Paulo
- Jun 2027A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine · Phase 3 · Bristol-Myers Squibb
- Nov 2026Obstructive Sleep Apnea Treatment in Serious Mental Illness · University of California, San Diego
- Nov 2026PROgram To Enhance Cardiovascular Risk Trough an Intervention of Nutrition in Bipolar Disorder · University of Sao Paulo
- Nov 2026Effects of Schizophrenia and Bipolar Disorder on Exercise Capacity, Pulmonary Function, and Quality of Life · Çankırı Karatekin University
- Nov 2026Venous Tourniquet vs. Arterial Tourniquet for Seizure Monitoring in ECT · Medipol University
- Nov 2026Group Intervention for Romantic Relationships in Young Adults With Severe Mental Illness · Centre hospitalier de Ville-Evrard, France
- Dec 2026Ketamine Associated ACC GABA and Glutamate Change and Depression Remission: · Mayo Clinic
- Dec 2026Probiotics to Prevent Relapse After Hospitalization for Bipolar Depression · Sheppard Pratt Health System
- Dec 2026The Bipolar Illness Onset Study (the BIO Study) · Mental Health Services in the Capital Region, Denmark
Who these studies take
Of the 203 Bipolar Disorder studies recruiting now, 59 (29%) set no upper age limit and 132 (65%) stop at 75 or younger. 37 (18%) take children under 18. 2 (1%) are for women only and 0 (0%) for men only; 49 (24%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 15 (7%) | 15 (7%) |
| 18 | 177 (87%) | 175 (86%) |
| 30 | 180 (89%) | 178 (88%) |
| 40 | 175 (86%) | 174 (86%) |
| 50 | 165 (81%) | 165 (81%) |
| 65 | 142 (70%) | 142 (70%) |
| 75 | 74 (36%) | 74 (36%) |
| 85 | 66 (33%) | 66 (33%) |
Across all 1,683 studies, recruiting or not: 68% stop at 75 or younger and 58% at 65; 18% take children; 2% are for women only and <1% for men only; 19% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
How long Bipolar Disorder studies take
Of 56 phase 2 interventional studies under Bipolar Disorder, half reached primary completion within 33 months of starting, counting those still running.
| Start to primary completion | Every sponsor | Industry | Non-industry |
|---|---|---|---|
| Phase 1 | 14 mo10–43 · 22 studies | — | — |
| Phase 2 | 33 mo20–60 · 56 studies | — | 49 mo21–63 · 42 studies |
| Phase 3 | 37 mo21–60 · 43 studies | 33 mo17–49 · 29 studies | — |
| Phase 4 | 43 mo25–60 · 44 studies | — | 50 mo25–61 · 39 studies |
| Interventional, no phase | 37 mo23–58 · 354 studies | — | 37 mo23–58 · 352 studies |
| Observational | 64 mo31–118 · 105 studies | — | 65 mo39–119 · 95 studies |
Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out
What changed recently
From the registry's own updates since Oct 13, 2026.
Started recruiting1
- Pramipexole vs Placebo Treatment in Bipolar Disorder With Anhedonic DepressionOct 22, 2026NCT07664852
Results posted1
- Assessment and Treatment for Chronic Pain in Veterans With Serious Mental IllnessOct 29, 2026NCT04118283
Stopped1
Newly registered13
- Sleep Monitoring for Early Detection of Relapse in People With Schizophrenia or Bipolar Disorder Receiving Usual TreatmentNov 6, 2026NCT07921667
- Pharmacokinetics and Relative Bioavailability of Intranasal vs Intramuscular Olanzapine in Healthy Adult ParticipantsNov 6, 2026NCT07921966
- Affective Cognitive Training in Mood Disorders and High-risk RelativesNov 5, 2026NCT07920302
- N-Acetylcysteine for Bipolar and Alcohol Use DisordersNov 3, 2026NCT07913542
- Neurostructural and Biochemical Signatures of Tobacco Smoking in Mood DisordersNov 2, 2026NCT07910318
Show 8 moreShow fewer
- A Prospective Study of Anxiety, Depression, and Bipolar Disorder in PeopleOct 29, 2026NCT07903246
- Validation of Wearable Core Body Temperature-Based Circadian Rhythm Digital BiomarkersOct 29, 2026NCT07905378
- Evaluating the PolarUs App in People With Bipolar DisorderOct 22, 2026NCT07890805
- Digital Phenotypes for Predicting Depression_ValidationOct 19, 2026NCT07880015
- French Minds Cohort: a French Longitudinal and Multimodal Cohort of Patients With Major Mood Disorders, Psychotic Disorders, Autism Spectrum Disorders, and Healthy ControlsOct 19, 2026NCT07881016
- Effect of Occupational Therapy on Psychosocial Parameters and Functioning in Individuals With Severe Mental IllnessOct 16, 2026NCT07879118
- A Mobile App to Support Mood, Daily Routines and Medication Adherence in Adults With Severe Mental IllnessOct 16, 2026NCT07879131
- BAROMETRE : Study on the Prognosis and Course of Individuals With Bipolar Spectrum DisorderOct 14, 2026NCT07872878
Studies
Recruiting first, then most recently updated. Showing 50 of 1,683. Browse all 1,683 → or search them.
- Time Restricted Eating (TRE) in Bipolar DisorderRecruitingNCT07211217Not applicable1 country
- Natural History of Depression, Bipolar Disorder and Suicide RiskRecruitingNCT064621961 country
- Pharmacokinetics and Relative Bioavailability of Intranasal vs Intramuscular Olanzapine in Healthy Adult ParticipantsNot yet recruitingNCT07921966Phase 1
- Sleep Monitoring for Early Detection of Relapse in People With Schizophrenia or Bipolar Disorder Receiving Usual TreatmentNot yet recruitingNCT079216671 country
- Safety and Feasibility of DBS for Bipolar DepressionRecruitingNCT07745374Not applicable1 country
- Affective Cognitive Training in Mood Disorders and High-risk RelativesRecruitingNCT07920302Not applicable1 country
- A Study of Brenipatide in Adult Participants With Bipolar Disorder (RENEW-Bipolar-1)RecruitingNCT07286175Phase 28 countries
- Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric PatientsRecruitingNCT06372964Phase 34 countries
- N-Acetylcysteine for Bipolar and Alcohol Use DisordersNot yet recruitingNCT07913542Phase 21 country
- Evaluation of the Impact of the EDIT-B® Blood Test on the Health Status of Patients Presenting a Major Depressive Episode. Clinical Utility and Medico-Economic AspectsRecruitingNCT06507787Not applicable1 country
- A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or LamotrigineRecruitingNCT07140913Phase 313 countries
- Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum DisorderRecruitingNCT06229210Phase 33 countries
- Psychophysiological Responses to Six Single-Session Self-Regulation Interventions in a Female Adult With ADHD and Stabilized Bipolar DisorderRecruitingNCT07437833Not applicable1 country
- Neurostructural and Biochemical Signatures of Tobacco Smoking in Mood DisordersNot yet recruitingNCT07910318
- A Prospective Study of Anxiety, Depression, and Bipolar Disorder in PeopleRecruitingNCT079032461 country
- Validation of Wearable Core Body Temperature-Based Circadian Rhythm Digital BiomarkersNot yet recruitingNCT07905378
- Lithium Versus Cariprazine in the Acute Phase Treatment of Bipolar Depression (DUAG9)RecruitingNCT05913947Phase 41 country
- Digital Phenotypes for Predicting Depression_ValidationEnrolling by invitationNCT078800151 country
- HD-tDCS for Adolescent Bipolar Depression Targeting S1RecruitingNCT07246044Not applicable1 country
- Incentives and Long-Acting Injectable Adherence After Involuntary HospitalizationEnrolling by invitationNCT07130500Not applicable1 country
- NMDA Receptor Modulation for the Treatment of Bipolar I DisorderRecruitingNCT05977023Phase 21 country
- Evaluating the PolarUs App in People With Bipolar DisorderNot yet recruitingNCT07890805Not applicable1 country
- Pramipexole vs Placebo Treatment in Bipolar Disorder With Anhedonic DepressionRecruitingNCT07664852Phase 31 country
- French Minds Cohort: a French Longitudinal and Multimodal Cohort of Patients With Major Mood Disorders, Psychotic Disorders, Autism Spectrum Disorders, and Healthy ControlsRecruitingNCT07881016Not applicable1 country
- Effect of Occupational Therapy on Psychosocial Parameters and Functioning in Individuals With Severe Mental IllnessNot yet recruitingNCT07879118Not applicable1 country
- A Mobile App to Support Mood, Daily Routines and Medication Adherence in Adults With Severe Mental IllnessNot yet recruitingNCT07879131Not applicable1 country
- Quality of Life, Safety and Compliance of Patients Using Monotherapy or Combinatorial Therapy With Quetiapine for Treatment of Schizophrenia or Bipolar Affective DisorderRecruitingNCT078585651 country
- BAROMETRE : Study on the Prognosis and Course of Individuals With Bipolar Spectrum DisorderNot yet recruitingNCT078728781 country
- ALTO-100 in Bipolar Disorder With Depression (BD-D)RecruitingNCT06656416Phase 22 countries
- Attentional Biases, Reward Sensitivity, and Cognitive Control in Adults With Bipolar DisorderRecruitingNCT038297871 country
- Evaluating the Impact of Ketogenic Therapy on Symptom Severity and Metabolic Side Effect Profile Among Individuals Living With Bipolar Disorder in A Rural Southern Catchment AreaNot yet recruitingNCT07570875Not applicable1 country
- Epigenetic Enhancement of Cognitive Training in Aging Mood and Schizophrenia Spectrum Disorder PopulationsRecruitingNCT07404085Not applicable1 country
- NIMH Rhythms and Blues Study: A Prospective Natural History Study of Motor Activity, Mood States, and Bipolar DisorderRecruitingNCT056697031 country
- Socio-cognitive and Biological Responses to MaltreatmentRecruitingNCT071011071 country
- Theta-Burst Stimulation for Bipolar DepressionRecruitingNCT06370988Not applicable1 country
- Multimodal Intervention to Support Hospital-to-Community Transition in Bipolar DisorderRecruitingNCT07213492Not applicable1 country
- Low Frequency Right Dorsolateral Pre Frontal Cortical Repetitive TMS for Bipolar DepressionRecruitingNCT06986460Phase 31 country
- Evaluation of Patients With Mood and Anxiety Disorders and Healthy VolunteersRecruitingNCT000246351 country
- Acceptability and Feasibility of Work-Oriented Social-Cognitive Skills Training for Veterans With Serious Mental IllnessRecruitingNCT05491538Not applicable1 country
- Pragmatic Patient-oriented Extension Study of Dialectical Behavior Therapy Booster Sessions for Youth With and/or at Familial Risk for Bipolar DisorderRecruitingNCT05627492Not applicable1 country
- Three-level Model of DBT-informed Care for Youth With and/or at Familial Risk for Bipolar Disorder (DB3)RecruitingNCT05153369Not applicable1 country
- Dialectical Behavior Therapy for Youth With and/or at Familial Risk for Bipolar DisorderRecruitingNCT05153382Not applicable1 country
- Effectiveness of mHealth Post-discharge Intervention for Patients With Severe Mental IllnessEnrolling by invitationNCT05703412Not applicable1 country
- Targeted Alternating Current and Cognitive Training Intervention for Cognitive Control in Bipolar DisordersNot yet recruitingNCT07845409Not applicable1 country
- Neuromodulation of Mood Switch Circuitry in Bipolar DisorderRecruitingNCT07680153Phase 41 country
- Cognition and Affective Research in ChinaNot yet recruitingNCT078332671 country
- Treatment Resistance in Psychiatric Disorders: the Search for Biological Markers Predictive of Response to TreatmentRecruitingNCT07741981Not applicable1 country
- Neuro-computational Study of Thymic Fluctuations in Mood DisordersRecruitingNCT07033923Not applicable1 country
- A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) InhibitorRecruitingNCT07105111Phase 41 country
- A Study to Assess Adverse Events and How Oral ABBV-932 Moves Through the Body When Given With Oral Itraconazole in Adult Participants With Bipolar DisorderRecruitingNCT07071532Phase 11 country